BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 15161686)

  • 21. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis.
    Maruyama Y; Ono M; Kawahara A; Yokoyama T; Basaki Y; Kage M; Aoyagi S; Kinoshita H; Kuwano M
    Cancer Res; 2006 Jun; 66(12):6233-42. PubMed ID: 16778198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer.
    Shin VY; Wu WK; Chu KM; Wong HP; Lam EK; Tai EK; Koo MW; Cho CH
    Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression level of vascular endothelial growth factor-C and -A in cultured human oral squamous cell carcinoma correlates respectively with lymphatic metastasis and angiogenesis when transplanted into nude mouse oral cavity.
    Nakazato T; Shingaki S; Kitamura N; Saito C; Kuwano R; Tachibana M
    Oncol Rep; 2006 Apr; 15(4):825-30. PubMed ID: 16525666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells.
    Yang AD; Camp ER; Fan F; Shen L; Gray MJ; Liu W; Somcio R; Bauer TW; Wu Y; Hicklin DJ; Ellis LM
    Cancer Res; 2006 Jan; 66(1):46-51. PubMed ID: 16397214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanism for IL-1 beta-mediated neovascularization unmasked by IL-1 beta knock-out mice.
    Amano K; Okigaki M; Adachi Y; Fujiyama S; Mori Y; Kosaki A; Iwasaka T; Matsubara H
    J Mol Cell Cardiol; 2004 Apr; 36(4):469-80. PubMed ID: 15081307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression.
    Itakura J; Ishiwata T; Friess H; Fujii H; Matsumoto Y; Büchler MW; Korc M
    Clin Cancer Res; 1997 Aug; 3(8):1309-16. PubMed ID: 9815813
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors.
    Gray MJ; Wey JS; Belcheva A; McCarty MF; Trevino JG; Evans DB; Ellis LM; Gallick GE
    Cancer Res; 2005 May; 65(9):3664-70. PubMed ID: 15867361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and regulation of vascular endothelial growth factor ligands and receptors during menstruation and post-menstrual repair of human endometrium.
    Punyadeera C; Thijssen VL; Tchaikovski S; Kamps R; Delvoux B; Dunselman GA; de Goeij AF; Griffioen AW; Groothuis PG
    Mol Hum Reprod; 2006 Jun; 12(6):367-75. PubMed ID: 16648151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803.
    Tian X; Song S; Wu J; Meng L; Dong Z; Shou C
    Biochem Biophys Res Commun; 2001 Aug; 286(3):505-12. PubMed ID: 11511087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of multiple vascular endothelial growth factor receptors (VEGFR) blocks lymph node metastases but inhibition of VEGFR-2 is sufficient to sensitize tumor cells to platinum-based chemotherapeutics.
    Sini P; Samarzija I; Baffert F; Littlewood-Evans A; Schnell C; Theuer A; Christian S; Boos A; Hess-Stumpp H; Foekens JA; Setyono-Han B; Wood J; Hynes NE
    Cancer Res; 2008 Mar; 68(5):1581-92. PubMed ID: 18316624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of IL-6 receptor in pancreatic cancer: involvement in VEGF induction.
    Masui T; Hosotani R; Doi R; Miyamoto Y; Tsuji S; Nakajima S; Kobayashi H; Koizumi M; Toyoda E; Tulachan SS; Imamura M
    Anticancer Res; 2002; 22(6C):4093-100. PubMed ID: 12553038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interferon-alpha in combination with chemotherapy has potent antiangiogenic properties in an orthotopic mouse model for pancreatic adenocarcinoma.
    Zhu Y; Tibensky I; Schmidt J; Hackert T; Ryschich E; Jäger D; Büchler MW; Märten A
    J Immunother; 2008 Jan; 31(1):28-33. PubMed ID: 18157009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
    Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
    Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.
    Weigand M; Hantel P; Kreienberg R; Waltenberger J
    Angiogenesis; 2005; 8(3):197-204. PubMed ID: 16328160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of vascular endothelial growth factor receptors during male germ cell differentiation in the mouse.
    Nalbandian A; Dettin L; Dym M; Ravindranath N
    Biol Reprod; 2003 Sep; 69(3):985-94. PubMed ID: 12773425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of potent VEGF blockade on experimental Wilms tumor and its persisting vasculature.
    Frischer JS; Huang J; Serur A; Kadenhe-Chiweshe A; McCrudden KW; O'Toole K; Holash J; Yancopoulos GD; Yamashiro DJ; Kandel JJ
    Int J Oncol; 2004 Sep; 25(3):549-53. PubMed ID: 15289855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inserting chromosome 18 into pancreatic cancer cells switches them to a dormant metastatic phenotype.
    Lefter LP; Sunamura M; Furukawa T; Takeda K; Kotobuki N; Oshimura M; Matsuno S; Horii A
    Clin Cancer Res; 2003 Oct; 9(13):5044-52. PubMed ID: 14581380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma.
    Lalla RV; Boisoneau DS; Spiro JD; Kreutzer DL
    Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):882-8. PubMed ID: 12925349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features.
    La Rosa S; Uccella S; Finzi G; Albarello L; Sessa F; Capella C
    Hum Pathol; 2003 Jan; 34(1):18-27. PubMed ID: 12605362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.